A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.
about
Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal DiseasesThe human mycobiome in health and diseaseAntibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activitiesAntibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin.Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosisA fungicidal monoclonal antibody protects against murine invasive candidiasis.Prospects for development of a vaccine to prevent and control vaginal candidiasis.Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicansVaccine and monoclonal antibody that enhance mouse resistance to candidiasisEffect of highly active antiretroviral therapy on vaginal Candida spp. isolation in HIV-infected compared to HIV-uninfected womenPassive antibody therapy for infectious diseases.New concepts in antibody-mediated immunity.Antibody Peptide based antifungal immunotherapyAnticandidal immunity and vaginitis: novel opportunities for immune intervention.Vaccines in the treatment of invasive candidiasis.Adaptive immune responses to Candida albicans infection.The potential of antibody-mediated immunity in the defence against biological weapons.A novel glyco-conjugate vaccine against fungal pathogens.Advances in combating fungal diseases: vaccines on the thresholdOpportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine.Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice.Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma.Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3pCharacterization of a monoclonal antibody directed against Salmonella enterica serovar Typhimurium and serovar [4,5,12:i:-].Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.Glycoconjugates and polysaccharides of fungal cell wall and activation of immune systemThe Efficacy of Humanized Antibody against the Sporothrix Antigen, gp70, in Promoting Phagocytosis and Reducing Disease Burden.Potential of anti-Candida antibodies in immunoprophylaxis.Candida albicans Als3, a multifunctional adhesin and invasin.T cell immunity and vaccines against invasive fungal diseases.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.Immunodetection of fungal and oomycete pathogens: established and emerging threats to human health, animal welfare and global food security.The protective role of immunoglobulins in fungal infections and inflammation.Peptides from the inside of the antibodies are active against infectious agents and tumours.Secretory component mediates Candida albicans binding to epithelial cells.Structural characterization and biological implications of sulfated N-glycans in a serine protease from the neotropical moth Hylesia metabus (Cramer [1775]) (Lepidoptera: Saturniidae).
P2860
Q26774692-45556970-E952-4A39-AC7A-F1CDDCDDF43EQ28295636-DE3ED41B-B0E4-4360-B296-15AADDE81152Q28472892-E576D8DB-FE8B-4905-A96F-26AA3D5B2BD0Q30974285-21F2791D-3D48-4A0D-B95E-F12ADE3B9628Q33255739-4C57A80D-0905-4CB4-9E74-67B5EA0FC212Q33282525-A1EFFC00-0B5E-4F0B-8EDA-A75C2E7A60BCQ33613647-6D3B0A67-50EE-44DF-9813-077F4DA357B6Q34045440-5CABDCD5-BD0E-47DB-B468-F0939FDBACE2Q34601994-CD65BE5C-C97D-4360-BDF6-632EA291AABAQ34707478-0007FCB4-0DF4-488F-9AFA-15A16FA6A6F4Q35065782-44109894-F3BA-4171-9E3C-7AE799F27402Q35271053-2921CB8E-74B8-4C05-84D6-4A7E10F60C0AQ35617437-BDAC7DA4-B288-4223-9CBB-E8CF0B519318Q35889582-6276202C-F252-4CD3-9E41-ECE7A37FA5FCQ35926507-06776201-FCDE-440C-9E12-8E19C32347A0Q36003400-A75F9BB9-1839-4C98-91AF-59FEFF533CC1Q36097307-DB32CDBC-6538-4864-92DB-19ED01A754EEQ36147010-11244464-77D7-42CE-AA69-74F75B07DA78Q36147114-D344A38F-5790-4A6C-ABC3-34613764F1AEQ36273411-4A10B528-4753-49AA-B114-B50871A23CBAQ36402820-E4CA6642-AEC8-454A-9D13-D1EBB4BB67A2Q36406460-A1B7167B-EFAF-4576-9557-184125D8C791Q36690302-C2AE6E05-A672-4117-A2CD-E1494638A6C8Q36757877-564D4621-292D-4B58-BFB3-2E7A5D3AC3CDQ36914682-F2808B47-2AD8-4030-AD81-0CB3C59DA67FQ36995716-BB87DDE8-D62C-43A9-9115-1B43D6747795Q37110471-5698E76D-3E35-4C7D-97F9-4EBEADD4EFCDQ37132306-066FD3FD-0A42-4920-8C90-2DD493A25AD7Q37159154-0E1732ED-960A-40E2-8B72-2CA70EF883CDQ37677956-A053930F-0A85-4818-B9DF-3EE694A67064Q37773252-0AF2DC11-BF76-4849-85FC-C11FFD38BD71Q37813335-87D6E4DA-8E99-4451-BA9E-C3375D4102EEQ37911513-0B66808C-A74E-49B1-8285-1BDB0939C64EQ38011299-B9D9DB26-5604-45D0-8E18-A95C0E9983F6Q38067451-BD738FCE-FA3B-46EC-970A-A350E852BA74Q38111802-56A82C6B-AEC0-42E3-B323-3B8F34A75C48Q38268922-CF212A0F-E4BF-4958-9BE9-B012D8C58E2BQ38371960-6190B799-DC47-4109-AD7E-B9C0B3093010Q38818819-0429CEAE-670A-4E94-A920-763B152D8C2EQ38928377-0AE334DC-FCC5-49CA-9002-3C06367D4724
P2860
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
A monoclonal antibody directed ...... e anti-C. albicans activities.
@ast
A monoclonal antibody directed ...... e anti-C. albicans activities.
@en
type
label
A monoclonal antibody directed ...... e anti-C. albicans activities.
@ast
A monoclonal antibody directed ...... e anti-C. albicans activities.
@en
prefLabel
A monoclonal antibody directed ...... e anti-C. albicans activities.
@ast
A monoclonal antibody directed ...... e anti-C. albicans activities.
@en
P2093
P2860
P1476
A monoclonal antibody directed ...... ee anti-C. albicans activities
@en
P2093
José Pontón
Luciano Polonelli
María J Sevilla
Miren J Omaetxebarria
Natalia Elguezabal
P2860
P304
P356
10.1128/IAI.71.9.5273-5279.2003
P407
P577
2003-09-01T00:00:00Z